Duquette, Pierre

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

A Gender Gap in Autoimmunity: Task Force on Gender, Multiple Sclerosis and Autoimmunity

Whitacre, C. C., Reingold, S. C., O'Looney, P. A., Blankenhorn, E., Brinley, F., Collier, E., Duquette, P., Fox, H., Giesser, B., Gilmore, W., et al. (1999) · Science

Multiple Sclerosis Research StudiesSystemic Lupus Erythematosus Research

Cited by 851

Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis

Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A. (2009) · Annals of Neurology

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 551

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Ribbons, K. A., McElduff, P., Boz, C., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Grand’Maison, F., Hupperts, R., Grammond, P., et al. (2015) · PLOS ONE

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 190

Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system

Larochelle, C., Cayrol, R., Kebir, H., Alvarez, J. I., Lécuyer, M.-A., Ifergan, I., Viel, É., Bourbonnière, L., Beauseigle, D., Terouz, S., et al. (2012) · Brain

Multiple Sclerosis Research StudiesCell Adhesion Molecules Research

Cited by 145

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

Kingwell, E., Leung, A. L., Roger, E., Duquette, P., Rieckmann, P., & Tremlett, H. (2010) · Journal of the Neurological Sciences

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 60

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

Lorscheider, J., Jokubaitis, V. G., Spelman, T., Izquierdo, G., Lugaresi, A., Havrdova, E., Horakova, D., Trojano, M., Duquette, P., Girard, M., et al. (2017) · Neurology

Multiple Sclerosis Research StudiesChronic Lymphocytic Leukemia Research

Cited by 44

Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes

Kang, H., Metz, L., Traboulsee, A., Eliasziw, M., Zhao, G., Cheng, Y., Zhao, Y., Li, D., the Minocycline in CIS Study Group, Traboulsee, A., et al. (2014) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 25

MS, MRI, and the 2010 McDonald criteria: A Canadian expert commentary

Selchen, D., Bhan, V., Blevins, G., Devonshire, V., Duquette, P., Grand’Maison, F., Kremenchutzky, M., Lapierre, Y., Li, D., von Riedemann, S. J., et al. (2012) · Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 25

Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis

Ramagopalan, S. V., Cukjati, M., Černilec, M., DeLuca, G. C., Dyment, D. A., Degenhardt, A., Sadovnick, A. D., Šerbec, V. Č., Ebers, G. C., & Duquette, P. (2008) · Journal of Neuroimmunology

Multiple Sclerosis Research StudiesIron Metabolism and Disorders

Cited by 16